South Wales, Sept. 25 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "WE NUKE CANCER" on Sept. 14. The details about the trademark application no. UK00004445014 published in the journal no. 2026/039 (Sept. 25).
With Dentons UK and Middle East LLP as representative, Actinium Pharmaceuticals, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Medicinal preparations for use in oncology; pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders; radiopharmaceutical preparations for the treatment of cancer.
Class 42 : Scientific research and development; Pharmaceutical research and development; Research and development of antibodies; Research and development of medicines; Research and development of new products; Research and development of conjugated antibodies; Research and development in the field of pharmaceuticals; Research and development of advanced learning technologies and teaching methods; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004445014
Disclaimer: Curated by HT Syndication.
